Micronuclei in circulating stromal cells correlates with PD-L1 expression and predicts progression in metastatic breast cancer

被引：0
|
作者：
Kasabwala, Dimpal M.
Cristofanilli, Massimo
Alpaugh, R. Katherine
Chumsri, Saranya
Reduzzi, Carolina
Tang, Cha-Mei
Lapidus, Rena G.
Del Priore, Giuseppe
Williams, William V.
Adams, Daniel L.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-304
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
304
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Correlation of micronuclei formation in circulating stromal cells with their PD-L1 expression and predicts for poorer clinical outcomes in metastatic breast cancer.
    Kasabwala, Dimpal M.
    Cristofanilli, Massimo
    Alpaugh, R. Katherine
    Chumsri, Saranya
    Tang, Cha-Mei
    Lapidus, Rena G.
    Del Priore, Giuseppe
    Chang, Mingjin
    Iwase, Toshiaki
    Ueno, Naoto T.
    Adams, Daniel L.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] PD-L1 expression by circulating breast cancer cells
    David, Rachel
    LANCET ONCOLOGY, 2015, 16 (07): : E321 - E321
  • [3] PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer
    Darga, Elizabeth P.
    Dolce, Emily M.
    Fang, Fang
    Kidwell, Kelley M.
    Gersch, Christina L.
    Kregel, Steven
    Thomas, Dafydd G.
    Gill, Anoop
    Brown, Martha E.
    Gross, Steven
    Connelly, Mark
    Holinstat, Michael
    Cobain, Erin F.
    Rae, James M.
    Hayes, Daniel F.
    Paoletti, Costanza
    PLOS ONE, 2021, 16 (11):
  • [4] Frequent expression of PD-L1 on circulating breast cancer cells
    Mazel, Martine
    Jacot, William
    Pantel, Klaus
    Bartkowiak, Kai
    Topart, Delphine
    Cayrefourcq, Laure
    Rossille, Delphine
    Maudelonde, Thierry
    Fest, Thierry
    Alix-Panabieres, Catherine
    MOLECULAR ONCOLOGY, 2015, 9 (09): : 1773 - 1782
  • [5] Tumor stromal type is associated with stromal PD-L1 expression and predicts outcomes in breast cancer
    Zhai, Qinglian
    Fan, Jiawen
    Lin, Qiulian
    Liu, Xia
    Li, Jinting
    Hong, Ruoxi
    Wang, Shusen
    PLOS ONE, 2019, 14 (10):
  • [6] Monitoring PD-L1 expression on circulating stromal cells in blood predicts PFS and OS in patients with metastatic NSCLC treated with PD-L1/PD-1 immunotherapy.
    Moran, Jillian
    Adams, Daniel L.
    Bravo, Pablo Lopez
    He, Jianzhong
    Qiao, Yawei
    Xu, Ting
    Liao, Zhongxing X.
    Gardner, Kirby P.
    Tang, Cha-Mei
    Lin, Steven H.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] PD-L1 expression on circulating epithelial tumor cells (CETCs) correlates with aggressiveness of tumor in breast cancer patients
    Schott, D.
    Pizon, M.
    Pachmann, U.
    Pachmann, K.
    CANCER RESEARCH, 2019, 79 (04)
  • [8] Isolation of circulating tumor cells and evaluation of PD-L1 expression in metastatic lung cancer
    Dhar, Manjima
    Che, James
    Wong, Jessica M.
    Pao, Edward
    Yu, Victor S. H.
    Matsumoto, Melissa
    Goldman, Jonathan
    Garon, Edward
    Sollier, Elodie
    Kulkarni, Rajan
    Di Carlo, Dino
    CANCER RESEARCH, 2015, 75
  • [9] PD-L1 expression on circulating monocytes in patients with breast cancer
    Nagano, M.
    Saito, K.
    Kozuka, Y.
    Shibusawa, M.
    Imai, N.
    Noro, A.
    Kageyama, Y.
    Mizuno, T.
    Ogawa, T.
    Katayama, N.
    ANNALS OF ONCOLOGY, 2018, 29
  • [10] Stromal PD-1/PD-L1 Expression Predicts Outcome in Colon Cancer Patients
    Wyss, Jacqueline
    Dislich, Bastian
    Koelzer, Viktor H.
    Galvan, Jose A.
    Dawson, Heather
    Hadrich, Marion
    Inderbitzin, Daniel
    Lugli, Alessandro
    Zlobec, Inti
    Berger, Martin D.
    CLINICAL COLORECTAL CANCER, 2019, 18 (01) : E20 - E38
12345